- Home
- MGRX vs XXII Comparison
MGRX vs XXII Comparison
Compare MGRX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- XXII
- Stock Information
- Founded
- MGRX 2021
- XXII 1998
- Country
- MGRX United States
- XXII United States
- Employees
- MGRX N/A
- XXII N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- XXII Medicinal Chemicals and Botanical Products
- Sector
- MGRX Technology
- XXII Health Care
- Exchange
- MGRX Nasdaq
- XXII Nasdaq
- Market Cap
- MGRX 8.1M
- XXII 7.0M
- IPO Year
- MGRX 2023
- XXII N/A
- Fundamental
- Price
- MGRX $1.50
- XXII $6.34
- Analyst Decision
- MGRX
- XXII
- Analyst Count
- MGRX 0
- XXII 0
- Target Price
- MGRX N/A
- XXII N/A
- AVG Volume (30 Days)
- MGRX 160.2K
- XXII 126.4K
- Earning Date
- MGRX 08-13-2025
- XXII 08-12-2025
- Dividend Yield
- MGRX N/A
- XXII N/A
- EPS Growth
- MGRX N/A
- XXII N/A
- EPS
- MGRX N/A
- XXII N/A
- Revenue
- MGRX $511,084.00
- XXII $23,869,000.00
- Revenue This Year
- MGRX N/A
- XXII $22.41
- Revenue Next Year
- MGRX N/A
- XXII $76.35
- P/E Ratio
- MGRX N/A
- XXII N/A
- Revenue Growth
- MGRX N/A
- XXII N/A
- 52 Week Low
- MGRX $1.32
- XXII $5.73
- 52 Week High
- MGRX $7.66
- XXII $2,837.04
- Technical
- Relative Strength Index (RSI)
- MGRX 45.69
- XXII 24.88
- Support Level
- MGRX $1.41
- XXII $5.73
- Resistance Level
- MGRX $2.04
- XXII $9.50
- Average True Range (ATR)
- MGRX 0.17
- XXII 0.92
- MACD
- MGRX -0.02
- XXII 0.30
- Stochastic Oscillator
- MGRX 33.43
- XXII 16.03
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.